Vaxart, Inc. announced a change in management. Effective immediately Andrei Floroiu, President and Chief Executive Officer of Vaxart, has announced his resignation from his positions with Vaxart as President and Director on Vaxart?s Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6229 USD | -5.38% | -9.54% | +8.75% |
Jul. 08 | HilleVax to discontinue development of norovirus vaccine for infants; shares plummet | RE |
Jun. 14 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.75% | 149M | |
+18.43% | 122B | |
+19.81% | 112B | |
-23.74% | 19.33B | |
-18.45% | 16.17B | |
-19.97% | 15.6B | |
-49.33% | 14.65B | |
+57.08% | 14.34B | |
+7.95% | 14B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- VXRT Stock
- News Vaxart, Inc.
- Vaxart, Inc. Announces Resignation of Andrei Floroiu as President and Director